To our knowledge, this is the first study to comprehensively perform the expression pattern, genetic alterations, prognostic value, and functional enrichment analyses of PLEK2 in HNSCC, which might help to find novel therapeutic targets. This evidence concerns the gene PLEK2 and head and neck squamous cell carcinoma.